ATAI Life Sciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $719 | $1,555 | $-5 | $40 |
Gross Profit | 719 | 1,555 | -5 | 40 |
EBITDA | -27,162 | -25,044 | -38,007 | -25,597 |
EBIT | -27,389 | -25,409 | -38,232 | -25,680 |
Net Income | -27,729 | -26,431 | -38,958 | -26,286 |
Net Change In Cash | 719 | 1,555 | -5 | 40 |
Free Cash Flow | -19,221 | -17,841 | -24,384 | -19,342 |
Cash | 61,940 | 48,287 | 17,505 | 29,963 |
Basic Shares | 196,563 | 176,271 | 160,159 | 160,621 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $308 | $314 | $233 | $20,376 |
Gross Profit | 308 | 314 | 65 | 20,329 |
EBITDA | -145,333 | -36,311 | -135,014 | -120,278 |
EBIT | -145,806 | -36,630 | -135,182 | -120,325 |
Net Income | -149,269 | -40,224 | -141,411 | -132,612 |
Net Change In Cash | 308 | 314 | 233 | 20,376 |
Cost of Revenue | -170,530 | |||
Free Cash Flow | -82,532 | -84,708 | -105,491 | -64,374 |
Cash | 17,505 | 45,034 | 190,613 | 362,266 |
Basic Shares | 160,159 | 158,833 | 155,719 | 160,677 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.14 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.24 |
